Goodwin Biotechnology Inc.

A fully integrated CGMP-compliant contract manufacturer of monoclonal antibodies and recombinant proteins for preclinical and Phase I and II clinical trials. The company's services span the spectrum from creation of fully qualified master and working cell banks, cell culture, and downstream purification of biologics products, to final fill. A Type V Facilities Drug Master File is on record with the FDA, as well as three Type II specific files.